About Asymmetric Suzuki Reactions
Asymmetric Suzuki Reactions is a company based in Oxford (United Kingdom) founded in 2019 by Sarah Morrow. It operates as a B2B. Asymmetric Suzuki Reactions has raised $84.55 thousand across 1 funding round from investors including Oxford Technology. The company has 1 employees as of February 28, 2021. Asymmetric Suzuki Reactions operates in a competitive market with competitors including Liberation Labs, NJ Bio, Shantani Proteome Analytics, Kinaxo Biotechnologies and Scala Biodesign, among others.
- Headquarter Oxford, United Kingdom
- Employees 1 as on 28 Feb, 2021
- Founders Sarah Morrow
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
- Legal Name Asymmetric Suzuki Reactions Limited
- Date of Incorporation 20 Feb, 2019
- Jurisdiction GRANTHAM, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$84.55 K (USD)
in 1 rounds
-
Latest Funding Round
$84.55 K (USD), Seed
Mar 18, 2019
- Investors
-
Employee Count
1
as on Feb 28, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Asymmetric Suzuki Reactions
Asymmetric Suzuki Reactions has successfully raised a total of $84.55K through 1 strategic funding round. The most recent funding activity was a Seed round of $84.55 thousand completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Asymmetric Suzuki Reactions
Asymmetric Suzuki Reactions has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Oxford Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Locked | Locked | Locked |
Investor details for Asymmetric Suzuki Reactions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asymmetric Suzuki Reactions
Investment portfolio details for Asymmetric Suzuki Reactions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Asymmetric Suzuki Reactions
Detailed financials for Asymmetric Suzuki Reactions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asymmetric Suzuki Reactions Comparisons
Peer comparison for Asymmetric Suzuki Reactions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asymmetric Suzuki Reactions
Asymmetric Suzuki Reactions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liberation Labs, NJ Bio, Shantani Proteome Analytics, Kinaxo Biotechnologies and Scala Biodesign, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fermentation products are manufactured and commercialized via CRO services.
|
|
| Locked | Locked | Locked |
Clinical development services are provided for biotechnology applications.
|
|
| Locked | Locked | Locked |
Drug discovery services are delivered via chemical-proteomics technologies.
|
|
| Locked | Locked | Locked |
Chemical proteomics for cellular target profiling and drug discovery services
|
|
| Locked | Locked | Locked |
Computational protein design solutions are delivered at scale.
|
|
| Locked | Locked | Locked |
Provider of peptide drug discovery and development services for global pharmaceutical industries
|
Detailed competitors of Asymmetric Suzuki Reactions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asymmetric Suzuki Reactions
Complete news archive for Asymmetric Suzuki Reactions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asymmetric Suzuki Reactions
Asymmetric Suzuki Reactions was founded in 2019.
Asymmetric Suzuki Reactions is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Sarah Morrow is the current CEO of Asymmetric Suzuki Reactions. They have also founded this company.
Asymmetric Suzuki Reactions is a funded company, having raised a total of $84.55K across 1 funding round to date.
As of Feb 28, 2021, the latest employee count at Asymmetric Suzuki Reactions is 1.
Asymmetric Suzuki Reactions operates with a B2B model, focusing on advancing biotech innovations, drug discovery, chemical proteomics, and research services. Delivers comprehensive chemical proteomics drug discovery services. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Asymmetric Suzuki Reactions's top competitors include Liberation Labs, NJ Bio and Shantani Proteome Analytics.
Asymmetric Suzuki Reactions has 1 investor. Key investors include Oxford Technology.